American Oncology Network, Inc.
AONCOTCHealthcare● Active
$12.00
+$2.00(+20.00%)
Market Cap$350980344
P/E Ratio—
52W High$14.25
52W Low$0.001
American Oncology Network, Inc. (AONC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AONC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.76B | $1.28B | $1.15B | $0.94B | $0.72B |
| Cost of Revenue | $1.64B | $1.20B | $1.05B | $0.87B | $0.66B |
| Gross Profit | $0.12B | $0.08B | $0.10B | $0.08B | $0.07B |
| Gross Margin %(computed) | 6.70% | 6.47% | 8.30% | 8.26% | 9.12% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.13B | $0.10B | $0.09B | $0.08B | $0.04B |
| Total Operating Expenses | $0.14B | $0.13B | $0.09B | $0.08B | $0.04B |
| Operating Income | ($0.02B) | ($0.05B) | $0.01B | $0.00B | $0.02B |
| Operating Margin %(computed) | -0.99% | -3.84% | 0.48% | 0.10% | 3.05% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.06B) | $0.00B | $0.00B | $0.02B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.00B) | ($0.01B) | $0.00B | ($0.00B) | $0.02B |
| Net Margin %(computed) | -0.23% | -0.43% | 0.23% | -0.01% | 3.03% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.69 | $-1.36 | $0.06 | $-0.00 | $0.74 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.04B | 0.04B | 0.03B |
| EBITDA | $0.00B | ($0.04B) | $0.02B | $0.01B | $0.03B |
| EBITDA Margin %(computed) | 0.10% | -3.08% | 2.01% | 0.83% | 3.58% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more American Oncology Network, Inc. data
About American Oncology Network, Inc. (AONC) Income Statement
American Oncology Network, Inc. (AONC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, AONC reported revenue of $1.76B, gross profit of $0.12B (gross margin 6.70%), and net income of ($0.00B) — a net profit margin of -0.23%.
Frequently asked questions
AONC · 4 questionsAmerican Oncology Network, Inc. (AONC) reported revenue of $1.76B for 2024, up 37.5% year-over-year.
AONC revenueAONC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09